Clinical application of novel blood biomarkers for dementia with Lewy bodies

Clinical application of novel serum peptide biomarkers for dementia with Lewy bodies - Application of serum peptide biomarkers for dementia with Lewy bodies

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000037213

Enrollment

600

Registered

2019-07-01

Start date

2018-02-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia with Lewy bodies, Alzheimer&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with the above target diseases in St. Marianna University Hospital. Healthy individuals who had a medical check in St. Marianna University Hospital. Healthy individuals who are staffs in St. Marianna University and St. Marianna University Hospital.

Exclusion criteria

Exclusion criteria: Patients with moderate or severe anemia.

Design outcomes

Primary

Measure	Time frame
To evaluate whether the biomarker models of serum peptide ion intensity distinguish dementia with Lewy bodies from other diseases and healthy condition	—

Secondary

Measure	Time frame
To evaluate the effect of the above peptides on neural cells	—

Countries

Japan

Contacts

Public ContactManae Kurokawa

St. Marianna University Graduate School of Medicine Disease Biomarker Analysis and Molecular Regulation

manae@marianna-u.ac.jp81-44-977-8111

Outcome results